PNPLA3 and liver disorder: The second sensitivity analysis using the Fine‐Gray competing risk model (adjusted for age, sex, BMI and T2D, as in the Cox models) still showed a significant association between the PNPLA3 G/G genotype and the risk of severe liver disease (sHR 2.17 95% CI = 1.19–3.95; adjusted sHR 2.21 95% CI = 1.11–4.40).